Replacing carbohydrates with vegetable fats lowers prostate CA mortality

This article originally appeared here.
Switch to Vegetable Fat May Cut Death Risk in Prostate Cancer
Switch to Vegetable Fat May Cut Death Risk in Prostate Cancer

(HealthDay News) -- For men with non-metastatic prostate cancer, the risks of lethal prostate cancer and all-cause mortality are significantly reduced with replacement of carbohydrates by vegetable fats, according to a study published online June 10 in JAMA Internal Medicine.

Erin L. Richman, Sc.D., from the University of California in San Francisco, and colleagues conducted a prospective study involving 4,577 men with non-metastatic prostate cancer to examine the correlation between post-diagnostic fat intake and outcomes (lethal prostate cancer and all-cause mortality).

During a median follow-up of 8.4 years, the researchers identified 315 lethal cancer events (distant metastases or prostate cancer-specific death) and 1,064 deaths. The risks of lethal prostate cancer and all-cause mortality were significantly reduced with replacement of 10 percent of energy intake from carbohydrate with vegetable fat (hazard ratios, 0.71 and 0.74, respectively). No association was seen with other fats and lethal prostate cancer. Higher all-cause mortality was seen with an increase in saturated and trans fats after diagnosis (replacement of 5 and 1 percent of energy from carbohydrates, respectively), with hazard ratios of 1.30 and 1.25, respectively.

"In conclusion, among men with non-metastatic prostate cancer, replacing carbohydrates and animal fat with vegetable fat may reduce the risk of all-cause mortality," the authors write. "The potential benefit of vegetable fat consumption for prostate cancer-specific outcomes merits further research."

Abstract
Full Text (subscription or payment may be required)

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs